COVID-19 has put the need for intensive care units (ICUs) and ventilators in the news every day. Ventilators help people breathe when they are unable to breathe adequately on their own. This treatment can cause physical pain. The use of intravenous sedation is considered integral in the care of ICU patients, especially those who are mechanically ventilated1. Sedation can protect a patient’s lungs, allowing them to heal. 2
Amneal Pharmaceuticals manufactures Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride injection, which is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.
Amneal is well-positioned to help meet the demand for Dexmedetomidine Hydrochloride for adult ICU Sedation. This medication is an AP-rated equivalent to Precedex® and ready-to-use with no admixing required. Amneal’s Dexmedetomidine Hydrochloride is not made with natural rubber latex and is free of preservatives.
Employees at Amneal are dedicated to going above and beyond during this time when ICUs and ventilators are at maximum capacities and patients require sedation.